HiCM-188
/ Help Therap, China Resources Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 11
Of
11
Go to page
1
June 16, 2025
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
(PRNewswire)
- "HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceutical companies, have announced a strategic partnership to co-develop and commercialize the investigational cell therapy HiCM-188 in Mainland China."
Licensing / partnership • Cardiovascular
April 01, 2024
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
(clinicaltrials.gov)
- P1/2 | N=36 | Recruiting | Sponsor: Help Therapeutics
New P1/2 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
January 17, 2024
HEAL-CHF: Treating Heart Failure With hPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Help Therapeutics | Trial completion date: May 2024 ➔ Oct 2024 | Trial primary completion date: Nov 2023 ➔ Apr 2024
Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
November 22, 2023
Treating Heart Failure With hiPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Help Therapeutics | Not yet recruiting ➔ Recruiting | Trial completion date: Dec 2024 ➔ Dec 2025 | Trial primary completion date: Jul 2023 ➔ Dec 2025
Enrollment open • Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
November 22, 2023
HEAL-CHF: Treating Heart Failure With hPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Help Therapeutics | Trial completion date: Jul 2023 ➔ May 2024 | Trial primary completion date: Dec 2022 ➔ Nov 2023
Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
November 22, 2023
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Help Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure
October 04, 2022
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Help Therapeutics
New P1 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
April 05, 2022
HEAL-CHF: Treating Heart Failure With hPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Help Therapeutics | Trial completion date: Dec 2022 ➔ Jul 2023 | Trial primary completion date: Dec 2021 ➔ Dec 2022
Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
March 25, 2022
Treating Heart Failure With hiPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Not yet recruiting | Sponsor: Help Therapeutics | Initiation date: Jan 2022 ➔ Apr 2022
Trial initiation date • Cardiovascular • Congestive Heart Failure • Heart Failure
February 04, 2022
Treating Heart Failure With hiPSC-CMs
(clinicaltrials.gov)
- P1/2 | N=20 | Not yet recruiting | Sponsor: Help Therapeutics
New P1/2 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
July 29, 2021
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
(clinicaltrials.gov)
- P1; N=20; Recruiting; Sponsor: Help Therapeutics
New P1 trial • Cardiomyopathy • Cardiovascular • Congestive Heart Failure • Heart Failure • MRI
1 to 11
Of
11
Go to page
1